Selegiline-transdermal--Somerset: Emsam

Drugs R D. 2003;4(1):59-60. doi: 10.2165/00126839-200304010-00012.
No abstract available

Publication types

  • Review

MeSH terms

  • Administration, Cutaneous
  • Antiparkinson Agents / administration & dosage
  • Antiparkinson Agents / adverse effects
  • Attention Deficit Disorder with Hyperactivity / drug therapy
  • Clinical Trials as Topic / statistics & numerical data
  • Depressive Disorder / drug therapy
  • Drugs, Investigational / administration & dosage*
  • Drugs, Investigational / adverse effects
  • Humans
  • Selegiline / administration & dosage*
  • Selegiline / adverse effects

Substances

  • Antiparkinson Agents
  • Drugs, Investigational
  • Selegiline